BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.250
-0.060 (-4.58%)
At close: Dec 24, 2025, 1:00 PM EST
1.270
+0.020 (1.58%)
After-hours: Dec 24, 2025, 4:22 PM EST
BioVie Employees
BioVie had 13 employees as of June 30, 2025. The number of employees decreased by 1 or -7.14% compared to the previous year.
Employees
13
Change (1Y)
-1
Growth (1Y)
-7.14%
Revenue / Employee
n/a
Profits / Employee
-$1,428,124
Market Cap
9.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 13 | -1 | -7.14% |
| Jun 30, 2024 | 14 | -4 | -22.22% |
| Jun 30, 2023 | 18 | 5 | 38.46% |
| Jun 30, 2022 | 13 | 7 | 116.67% |
| Jun 30, 2021 | 6 | 2 | 50.00% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BIVI News
- 16 hours ago - HALPER SADEH LLC ENCOURAGES BIOVIE INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 15 days ago - BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease Transcript - Seeking Alpha
- 5 weeks ago - Join Biovie's Exclusive Live Investor Webinar and Q&A Session on December 9 - GlobeNewsWire
- 2 months ago - Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 2 months ago - BioVie Inc. - Special Call - Seeking Alpha
- 3 months ago - BioVie to Host Live Investor Webinar and Q&A on Oct. 8 - GlobeNewsWire
- 4 months ago - BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes - GlobeNewsWire
- 4 months ago - BioVie Inc. Announces Pricing of $12 Million Public Offering - GlobeNewsWire